Unlock instant, AI-driven research and patent intelligence for your innovation.

Solid preparation of azilsartan and amlodipine besylate composition and preparation method thereof

A technology of amlodipine besylate and amlodipine besylate, applied in the direction of drug combination, medical preparations with non-active ingredients, medical preparations containing active ingredients, etc., can solve the problem of poor stability of compound preparations and other issues to achieve good stability

Active Publication Date: 2020-06-23
JIANGSU SIMCERE PHARMA
View PDF4 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] In March 2014, Azilsartan and Amlodipine Tablets, developed by Takeda Pharmaceutical Co., Ltd., were approved for marketing in Japan. For the treatment of hypertension, the product has good bioavailability and in vitro dissolution; however, in the It was found in the study that both azilsartan and amlodipine besylate are relatively stable, but the stability of the compound preparation obtained by mixing the two is not very good

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Solid preparation of azilsartan and amlodipine besylate composition and preparation method thereof
  • Solid preparation of azilsartan and amlodipine besylate composition and preparation method thereof
  • Solid preparation of azilsartan and amlodipine besylate composition and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0046] The present invention provides a preparation method of the solid preparation of the present invention, comprising:

[0047] mixing the granules containing azilsartan, the granules containing amlodipine besylate and pharmaceutically acceptable auxiliary materials to obtain a solid preparation;

[0048] Or a solid preparation is obtained by mixing granules containing azilsartan, amlodipine besylate and pharmaceutically acceptable auxiliary materials;

[0049] Or by mixing granules containing amlodipine besylate, azilsartan and pharmaceutically acceptable auxiliary materials to obtain a solid preparation;

[0050] The azilsartan-containing particles include azilsartan and polyethylene glycol;

[0051] The granules containing amlodipine besylate include amlodipine besylate and starch.

[0052] According to the present invention, the granules containing azilsartan, the granules containing amlodipine besylate and pharmaceutically acceptable auxiliary materials are mixed to ...

Embodiment 1

[0075] Preparation process: Pass the auxiliary materials through a 60-mesh sieve respectively, mix amlodipine besylate and starch evenly according to the method of equal increments, add an appropriate amount of purified water to make a soft material, granulate with a 20-mesh sieve, dry at 60°C, and sieve with a 20-mesh sieve Whole grain, recorded as granule 1; mix azilsartan with microcrystalline cellulose, hydroxypropyl cellulose, hydroxypropyl cellulose SL, polyethylene glycol 6000 evenly, add water to make soft material, sieve with 20 mesh granules, dried at 60°C, sieved with a 20-mesh sieve, and recorded as granule 2. Mix granules 1 and 2 evenly, add magnesium stearate, compress tablets or fill capsules, which is a solid preparation; wherein, the dosage of each raw material is shown in Table 5, and Table 5 is the azilsartan and The formulation of the solid preparation of amlodipine besylate composition.

[0076] The formula of the solid formulation of the azilsartan and a...

Embodiment 2

[0080] Preparation process: Pass the excipients through a 60-mesh sieve, mix amlodipine besylate and pregelatinized starch evenly by the method of equal increments, add an appropriate amount of purified water to make a soft material, granulate with a 20-mesh sieve, and dry at 60°C. 20-mesh sieve for granulation, recorded as granule 1; polyethylene glycol 1000 was added into water to dissolve to make a polyethylene glycol solution, azilsartan was mixed with lactose, hydroxypropyl cellulose, and povidone K30 evenly, and polyvinyl alcohol was added The ethylene glycol solution is made into a soft material, granulated with a 20-mesh sieve, dried at 60°C, and granulated with a 20-mesh sieve, which is recorded as granule 2. Mix granules 1 and 2 evenly, add magnesium stearate, and compress into tablets to obtain tablet cores. The film coating premix and purified water are prepared into a 12%-18% (w / w) suspension, and the tablet core is film-coated to obtain a coated tablet, which is ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a solid preparation of an azilsartan and levamlodpine besylate composition and a preparation method of the solid preparation. The solid preparation provided by the invention is prepared by adopting particles containing azilsartan and / or particles containing levamlodpine besylate, wherein the particles containing the azilsartan are prepared by compounding azilsartan and polyethylene glycol, and the particles containing the levamlodpine besylate are prepared by compounding the levamlodpine besylate and starch, so that the prepared solid preparation has good in vitro dissolution and is good in stability.

Description

technical field [0001] The field of pharmaceutical preparations of the present invention particularly relates to a solid preparation of azilsartan and amlodipine besylate composition and a preparation method thereof. Background technique [0002] Hypertension is a disease caused by a variety of complex factors. Its occurrence and persistence are related to blood volume, cardiac function, vascular tension and other factors. Currently, the mechanisms of action of antihypertensive drugs in clinical use are also different. Usually, an antihypertensive drug can only affect part of the mechanism of hypertension, and its antihypertensive effect has certain limitations. However, compound preparations have the advantages of less adverse reactions, simple medication, and good compliance. first choice. [0003] Azilsartan, chemical name 2-ethoxy-1-[[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl ) biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid, which has the structure shown in ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/4422A61K9/16A61K47/36A61K47/10A61P9/12A61K31/4245
Inventor 嵇元欣李玲李晓强
Owner JIANGSU SIMCERE PHARMA